Aditxt, Inc. (ADTX)
NASDAQ: ADTX · Real-Time Price · USD
0.5173
-0.0022 (-0.42%)
Apr 8, 2026, 10:16 AM EDT - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Discovery and Development of Biopharmaceutical Products | 133.99K | 645.18K | 933.72K | 105.03K | | | | |
Discovery and Development of Biopharmaceutical Products Growth | -79.23% | -30.90% | 788.96% | - | | | | |
| 133.99K | 645.18K | 933.72K | 105.03K | | | | |
| -79.23% | -30.90% | 788.96% | - | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 133.99K | 645.18K | 933.72K | 105.03K | | | | |
| -79.23% | -30.90% | 788.96% | - | | | | |
| 133.99K | 645.18K | 933.72K | 105.03K | | | | |
| -79.23% | -30.90% | 788.96% | - | | | | |
Source: S&P Global Market Intelligence.
